The portfolio maintains a sizable cost advantage over competitors, priced within the least expensive fee quintile among peers.
Nuveen International Eq Idx Retire TRIEX
- NAV / 1-Day Return 24.01 / +1.18 %
- Total Assets 25.2 Bil
-
Adj. Expense Ratio
- Expense Ratio 0.300%
- Distribution Fee Level Low
- Share Class Type Retirement, Large
- Category Foreign Large Blend
- Investment Style Large Blend
- Min. Initial Investment —
- Status Open
- TTM Yield 2.68%
- Turnover 8%
USD | NAV as of Jul 26, 2024 | 1-Day Return as of Jul 26, 2024, 11:32 PM GMT+0
Morningstar’s Analysis TRIEX
Will TRIEX outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 15.1
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
---|---|---|---|
Novo Nordisk A/S Class B | 2.53 | 644.2 Mil | Healthcare |
ASML Holding NV | 2.19 | 557.0 Mil | Technology |
Nestle SA | 1.62 | 412.9 Mil | Consumer Defensive |
AstraZeneca PLC | 1.36 | 347.2 Mil | Healthcare |
Shell PLC | 1.33 | 337.2 Mil | Energy |
Toyota Motor Corp | 1.32 | 336.6 Mil | Consumer Cyclical |
Lvmh Moet Hennessy Louis Vuitton SE | 1.26 | 321.3 Mil | Consumer Cyclical |
Msci Eafe Jun24 Ifus 20240621 | 1.19 | 301.8 Mil | — |
Novartis AG Registered Shares | 1.17 | 297.2 Mil | Healthcare |
SAP SE | 1.09 | 277.4 Mil | Technology |